What compounds target CSNK1D?

BiohacksAI has identified 32 compounds that interact with CSNK1D (casein kinase 1 delta). Top compounds include: gefitinib, erlotinib, sb 203580, seliciclib, bosutinib. Each compound is ranked by evidence score derived from PubMed bioassay confidence and assay count.

What is CSNK1D (casein kinase 1)?

CSNK1D is casein kinase 1 delta. It is a molecular target for 32 compounds documented in PubMed bioassay data. NCBI Gene ID: 1453.

CSNK1D

MOLECULAR TARGET

casein kinase 1 delta

NCBI Gene: 145332 compounds

CSNK1D (casein kinase 1 delta) is targeted by 32 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CSNK1D

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#	Compound	Confidence	Active Assays
1	gefitinib	5.67	290
2	erlotinib	5.55	256
3	sb 203580	4.92	136
4	seliciclib	4.91	135
5	bosutinib	4.08	58
6	bi 2536	4.01	54
7	sb 202190	3.64	37
8	nintedanib	3.61	36
9	canertinib	3.53	33
10	pelitinib	3.50	32
11	bms 387032	3.47	31
12	cgs 15943	3.47	31
13	sb 431542	3.33	27
14	hymenialdisine	3.00	19
15	galunisertib	2.94	18
16	milciclib	2.77	15
17	pha 665752	2.71	14
18	azd 5438	2.71	14
19	kw 2449	2.64	13
20	ast 487	2.56	12
21	zotiraciclib	2.56	12
22	ic261	2.30	9
23	su 014813	2.20	8
24	gsk 1070916	2.20	8
25	cyc 116	2.08	7
26	tg100 115	2.08	7
27	gsk 1059615	1.95	6
28	tak 715	1.79	5
29	Harmine Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is	1.10	2
30	sp600125	1.10	2
31	alsterpaullone	0.69	1
32	pictilisib	0.69	1

About CSNK1D as a Drug Target

CSNK1D (casein kinase 1 delta) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 32 compounds with documented CSNK1D interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CSNK1D inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.